Fibon Bhd
KLSE:FIBON
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
Fibon Bhd
KLSE:FIBON
|
MY |
|
N
|
Nightingale Health Oyj
OMXH:HEALTH
|
FI |
|
Siren Gold Ltd
ASX:SNG
|
AU |
|
D
|
Dongwu Cement International Ltd
HKEX:695
|
CN |
|
Alexandria Real Estate Equities Inc
NYSE:ARE
|
US |
|
Hunting PLC
LSE:HTG
|
UK |
Balance Sheet
Balance Sheet Decomposition
Fibon Bhd
Fibon Bhd
Balance Sheet
Fibon Bhd
| May-2008 | May-2009 | May-2010 | May-2011 | May-2012 | May-2013 | May-2014 | May-2015 | May-2016 | May-2017 | May-2018 | May-2019 | May-2020 | May-2021 | May-2022 | May-2023 | May-2024 | May-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Cash & Cash Equivalents |
4
|
2
|
3
|
3
|
4
|
5
|
8
|
9
|
16
|
26
|
28
|
29
|
31
|
33
|
35
|
39
|
5
|
7
|
|
| Cash |
4
|
2
|
3
|
3
|
4
|
5
|
8
|
9
|
16
|
26
|
28
|
29
|
31
|
33
|
35
|
39
|
5
|
7
|
|
| Short-Term Investments |
1
|
9
|
12
|
11
|
14
|
15
|
14
|
17
|
12
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
37
|
36
|
|
| Total Receivables |
4
|
6
|
3
|
5
|
5
|
6
|
7
|
5
|
9
|
6
|
5
|
7
|
6
|
5
|
7
|
6
|
6
|
7
|
|
| Accounts Receivables |
4
|
6
|
3
|
5
|
5
|
6
|
5
|
4
|
8
|
6
|
5
|
6
|
6
|
4
|
6
|
5
|
4
|
6
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Inventory |
1
|
1
|
1
|
2
|
1
|
1
|
1
|
2
|
1
|
1
|
2
|
1
|
2
|
1
|
1
|
2
|
2
|
1
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
10
|
19
|
20
|
21
|
24
|
27
|
30
|
33
|
38
|
33
|
35
|
37
|
39
|
40
|
43
|
47
|
50
|
51
|
|
| PP&E Net |
1
|
1
|
1
|
4
|
5
|
6
|
6
|
6
|
5
|
13
|
13
|
13
|
13
|
13
|
13
|
13
|
15
|
17
|
|
| PP&E Gross |
1
|
1
|
1
|
4
|
5
|
6
|
6
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
13
N/A
|
20
+61%
|
22
+8%
|
26
+19%
|
30
+14%
|
34
+14%
|
37
+8%
|
40
+8%
|
44
+12%
|
47
+6%
|
49
+3%
|
50
+4%
|
53
+4%
|
54
+2%
|
57
+5%
|
61
+8%
|
65
+6%
|
68
+5%
|
|
| Liabilities | |||||||||||||||||||
| Accounts Payable |
1
|
0
|
0
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
1
|
2
|
3
|
3
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
4
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
6
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
3
|
3
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
6
N/A
|
2
-73%
|
1
-39%
|
2
+69%
|
2
+15%
|
2
-10%
|
2
-1%
|
2
+17%
|
3
+29%
|
2
-22%
|
2
-10%
|
2
-6%
|
3
+50%
|
2
-5%
|
2
-7%
|
3
+22%
|
3
+23%
|
4
+6%
|
|
| Equity | |||||||||||||||||||
| Common Stock |
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
|
| Retained Earnings |
3
|
8
|
11
|
14
|
18
|
22
|
25
|
27
|
31
|
35
|
37
|
38
|
40
|
41
|
44
|
48
|
51
|
54
|
|
| Additional Paid In Capital |
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
7
N/A
|
19
+177%
|
21
+12%
|
25
+17%
|
28
+14%
|
32
+15%
|
35
+9%
|
38
+7%
|
42
+11%
|
45
+8%
|
47
+4%
|
49
+4%
|
50
+3%
|
51
+3%
|
54
+6%
|
58
+7%
|
62
+6%
|
65
+5%
|
|
| Total Liabilities & Equity |
13
N/A
|
20
+61%
|
22
+8%
|
26
+19%
|
30
+14%
|
34
+14%
|
37
+8%
|
40
+8%
|
44
+12%
|
47
+6%
|
49
+3%
|
50
+4%
|
53
+4%
|
54
+2%
|
57
+5%
|
61
+8%
|
65
+6%
|
68
+5%
|
|
| Shares Outstanding | |||||||||||||||||||
| Common Shares Outstanding |
98
|
98
|
98
|
98
|
98
|
98
|
98
|
98
|
98
|
98
|
98
|
98
|
98
|
98
|
98
|
98
|
98
|
98
|
|